Biology Reference
In-Depth Information
Flinn, L., Mortiboys, H., Volkmann, K., Koster, R. W., Ingham, P. W., and Bandmann, O. (2009).
Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio
rerio). Brain 132, 1613-1623.
Forno, L. S. (1996). Neuropathology of Parkinson's disease.
J. Neuropathol. Exp. Neurol.
55,
259-272.
Freeman, M. (2008). Rhomboid proteases and their biological functions. Annu. Rev. Genet. 42,
191-210.
Freeman, M. (2009). Rhomboids: 7 years of a new protease family. Semin. Cell Dev. Biol. 20,
231-239.
Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G. V., Rudka, T.,
Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B., et al. (2006). OPA1 controls
apoptotic cristae remodeling independently from mitochondrial fusion.
Cell 126, 177-189.
Friggi-Grelin, F., Coulom, H., Meller, M., Gomez, D., Hirsh, J., and Birman, S. (2003). Targeted gene
expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase.
J. Neurobiol. 54, 618-627.
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J.,
Takio, K., and Iwatsubo, T. (2002). alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Nat. Cell Biol. 4, 160-164.
Gandhi, S., and Wood, N. W. (2010). Genome-wide association studies: The key to unlocking
neurodegeneration?
Nat. Neurosci. 13, 789-794.
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J.,
Latchman, D. S., Tabrizi, S. J., Wood, N. W.,
. (2009). PINK1-associated Parkinson's disease
is caused by neuronal vulnerability to calcium-induced cell death.
et al
Mol. Cell 33, 627-638.
Gasser, T. (2009). Molecular pathogenesis of Parkinson disease: Insights from genetic studies.
Expert
Rev. Mol. Med. 11, e22.
Gegg, M. E., Cooper, J. M., Schapira, A. H., and Taanman, J. W. (2009). Silencing of PINK1
expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS
ONE 4, e4756.
Gehrke, S., Imai, Y., Sokol, N., and Lu, B. (2010). Pathogenic LRRK2 negatively regulates micro-
RNA-mediated translational repression. Nature 466, 637-641.
Geisler, S., Holmstrom, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., and Springer, W.
(2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat.
Cell Biol. 12, 119-131.
Gong, W. J., and Golic, K. G. (2003). Ends-out, or replacement, gene targeting in Drosophila. Proc.
Natl. Acad. Sci. USA 100, 2556-2561.
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., and Pallanck, L. J. (2003).
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc.
Natl. Acad. Sci. USA 100, 4078-4083.
Greene, J. C., Whitworth, A. J., Andrews, L. A., Parker, T. J., and Pallanck, L. J. (2005). Genetic and
genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune
responses in pathogenesis.
Hum. Mol. Genet. 14, 799-811.
Groth, A. C., Fish, M., Nusse, R., and Calos, M. P. (2004). Construction of transgenic Drosophila by
using the site-specific integrase from phage phiC31.
Genetics 166, 1775-1782.
Gupta, A., Dawson, V. L., and Dawson, T. M. (2008). What causes cell death in Parkinson's disease?
Ann. Neurol. 64(Suppl. 2), S3-S15.
Hao, L. Y., Giasson, B. I., and Bonini, N. M. (2010). DJ-1 is critical for mitochondrial function and
rescues PINK1 loss of function.
Proc. Natl. Acad. Sci. USA 107, 9747-9752.
Haque, M. E., Thomas, K. J., D'Souza, C., Callaghan, S., Kitada, T., Slack, R. S., Fraser, P.,
Cookson, M. R., Tandon, A., and Park, D. S. (2008). Cytoplasmic Pink1 activity protects neurons
from dopaminergic neurotoxin MPTP.
Proc. Natl. Acad. Sci. USA 105, 1716-1721.
